Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2018
August 2018, Vol 9, No 2
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Bevacizumab plus Chemotherapy Approved for Several Types of Ovarian Cancer
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Keytruda Receives 2 New Indications: Metastatic Cervical Cancer and Relapsed Mediastinal Large B-Cell Lymphoma
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Venclexta Indicated for CLL or SLL, Alone or in Combination with Rituxan
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Tafinlar-Mekinist Combination Approved for Metastatic Thyroid Cancer with BRAF V600E Mutation
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Kymriah Approved for Adults with Relapsed or Refractory Large B-Cell Lymphoma
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Pomalidomide Added to the Regimen in First Relapse Extends PFS in Multiple Myeloma
By
Wayne Kuznar
Clinical Trials
,
Multiple Myeloma
,
Hematologic Malignancies
,
Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Nelarabine Therapy Up Front Boosts Survival in T-Cell Leukemia and Lymphoma
By
Phoebe Starr
Hematologic Malignancies
,
Leukemia
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Next-Generation Sequencing Could Help Treatment Decisions in Acute Myeloid Leukemia
By
Chase Doyle
Leukemia
,
Hematologic Malignancies
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
Timing of Palliative Care Consults Affects Healthcare Utilization in Elderly Patients with Pancreatic Cancer
By
Chase Doyle
Pancreatic Cancer
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected
By
Wayne Kuznar
Lynch Syndrome
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Based on results of a study presented at ASCO 2018, the presence of an MSI-H or dMMR tumor signature, regardless of cancer type or family history, should prompt genetic testing to evaluate for Lynch syndrome.
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Perioperative Nivolumab Extends Event-Free Survival in Resectable NSCLC
William King
2.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
3.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma